← Back to Search

Behavioral Intervention

Health Program for Sign Language Interpreters' Well-Being

N/A

Waitlist Available

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Certified sign language interpreter working at least 10 hours/week in any interpreter setting

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 6 months post intervention (approximately 21-30 months)

Awards & highlights

Study Summary

This trial will test a program to improve well-being of sign language interpreters. It will compare those in the program to those not in it to measure its efficacy.

Who is the study for?

This trial is for certified sign language interpreters who are bilingual in English and American Sign Language, generally healthy, and work at least 10 hours a week. It's not suitable for those under 18, uncertified individuals, or anyone unable to give consent.Check my eligibility

What is being tested?

The study is testing the effectiveness of a Total Worker Health program tailored for sign language interpreters' well-being against a general health program. Participants will be randomly assigned to one of these two groups to compare outcomes.See study design

What are the potential side effects?

Since this trial focuses on health promotion rather than medication or medical procedures, traditional side effects are not expected. However, participants may experience changes in stress levels or personal habits.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I work as a certified sign language interpreter for at least 10 hours a week.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 6 months post intervention (approximately 21-30 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 6 months post intervention (approximately 21-30 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months post intervention (approximately 21-30 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

mean change in Acceptability, Feasibility, and Appropriateness Scale

mean change in acceptability using the Training Acceptability Rating Scale-1 (TARS-1)

mean change in acceptability using the Training Acceptability Rating Scale-2 (TARS-2)

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Health Protection and Promotion ProgramExperimental Treatment1 Intervention

Group II: General Health ProgramActive Control1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED

875 Previous Clinical Trials

22,477,269 Total Patients Enrolled

University of RochesterLead Sponsor

836 Previous Clinical Trials

518,035 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open enrolment slots for this clinical research?

"Currently, according to clinicaltrials.gov, this particular trial is not enrolling patients at the moment; it was initially posted on November 1st 2023 and last updated September 21st 2023. However, there are 13 other studies actively recruiting participants presently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Health Protection and Promotion of Sign Language Interpreters Through Implementation of Total Worker Health®

Gretchen Roman 2024. "Health Protection and Promotion of Sign Language Interpreters Through Implementation of Total Worker Health®". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06058949.